Free press releases distribution network?

Agency / Source: Sciformix Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Sciformix to Showcase Clinical Research and Post-Approval Support Capabilities at DIA Clinical Forum - Sciformix Corporation, a world leading Scientific Process Organization (SPO), will be showcasing its its new SLIM™ Operational Model delivers excellence in scientific and operation efficiency - Sciformix.com
Sciformix to Showcase Clinical Research and Post-Approval Support Capabilities at DIA Clinical Forum

 

PRZOOM - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2013/10/04 - Sciformix Corporation, a world leading Scientific Process Organization (SPO), will be showcasing its its new SLIM™ Operational Model delivers excellence in scientific and operation efficiency - Sciformix.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

1st October 2013 Sciformix Corporation, a leading Scientific Process Organization (SPO), will showcase its end-to-end capabilities in Clinical Research and Post-Approval Support Services (CRPASS), including the new SLIM™ Operational Model for post-approval and late-phase studies at booth #14B at DIA Clinical Forum, being held October 8-9 at the Dublin Convention Center in Dublin, Ireland. In addition, the company’s practice head for CRPASS will share her insights and experiences in the presentation on “The Importance of Patient Registries and Their Application in Emerging Markets”.

Incorporating Sciformix’s comprehensive experience in partnering with clients in CRPASS, the SLIM™ Operational Model forms an integral part of Sciformix’s post-approval support service to ensure clients optimize their products’ success and full potential in the marketplace. SLIM™ incorporates seamless end-to-end support from clinical trial start-up to close-out, lean and flexible processes, an IT and EDC enabled secure and compliant platform, and multi-functional expertise provided by a team of clinical operations specialists, statisticians, programmers, medical experts and writers.

SLIM™ is employed to support a wide range of post-approval studies including non-interventional studies, investigator-initiated research, epidemiology studies, and patient registries. These services focus on gathering real-world data to enable clients to have a better understanding of their products’ long-term safety issues and to meet specific regulatory requirements. These services form part of Sciformix’s comprehensive suite of offerings to be showcased at DIA Clinical Forum, including other offerings such as medical information and communication support, and market and competitive intelligence.

The presentation by Dr. Samyuktha Ajay, Practice Head for CRPASS at Sciformix, will take place on Tuesday, October 8th from 9:00 to 10:30 AM. Dr. Ajay will discuss the importance of Patient Registries in contributing towards access to better and safer treatments and informed decision-making for patient care and healthcare policy in the developing world. As an important element of risk management within an integrated drug safety program, Patient Registries provide the real-world data that complements the body of evidence obtained during clinical development and aid informed decision making.

Dr Ajay comments: “We understand how the operational requirements of Patient Registries and other post-approval studies are different from those of clinical trials and also understand the challenges in emerging markets. Sciformix offers best-in-class expertise in conceptualizing and designing registries and post-approval studies using the SLIM™ model to address the operational challenges. We have seen a lot of interest and success with this approach. ”

As this year’s overall theme “Rebooting Clinical Development” suggests, Europe and the rest of the world is entering a new era in Clinical Development, largely in response to substantial challenges the pharmaceutical industry has recently faced with respect to the increasing costs and decreasing success rates of clinical trials. Emphasis on emerging markets, post-approval studies and virtual trial management are a few key areas the industry is focusing on to address these challenges. Sciformix offers solutions in these areas, and partners with clients through the entire drug development cycle to provide a broad range of services from study design to post marketing surveillance and commercialization support.

To meet with us at DIA and/or receive a copy of the presentation, contact us at Bizteam[.]sciformix.com or call us at +1.877.576.5005
For further press information please contact: Susan Najjar, Director of Marketing, Sciformix Corporation: P: +1 617-264-0339 - E: susan.najjar[.]sciformix.com.

About Sciformix
Sciformix Corporation (sciformix.com) is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies - in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs. Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fueled by an unrivaled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sciformix Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sciformix to Showcase Clinical Research and Post-Approval Support Capabilities at DIA Clinical Forum

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Sciformix Corporation |
Contact: David Bertram - ScottPR.com for Sciformix 
+44(0)14 7753 9539 sciformix[.]scottpr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sciformix Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sciformix Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Triggr & Bloom

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today